Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Questcor: Why Analysts Are Improving Its Ratings Now
Seeking Alpha
Thursday, July 12, 2012 - 10:58am
tags:
Questcor, Alkermes, Arena Pharmaceuticals, Vivus, Orexigen
Can Exelixis Continue Making Big Moves?
Seeking Alpha
Thursday, July 12, 2012 - 10:56am
tags:
Exelixis, cabozantinib
Arena files for approval of Belviq in Switzerland
Yahoo/AP
Thursday, July 12, 2012 - 10:55am
tags:
Switzerland, obesity, Arena Pharmaceuticals, Belviq
Vivus: A New Twist On The Qnexa Story
Seeking Alpha
Thursday, July 12, 2012 - 10:54am
tags:
Qnexa, Vivus, obesity
GlaxoSmithKline says data from diabetes drug study positive
Yahoo/Fly on the Wall
Wednesday, July 11, 2012 - 12:45pm
tags:
GSK, diabetes, albiglutide
4 Small-Cap Pharma Stocks With Zero Debt To Consider Currently
Seeking Alpha
Wednesday, July 11, 2012 - 12:42pm
tags:
Osiris, Depomed, Opexa, Neurostem
Coming Soon: Johnson & Johnson Earnings
Motley Fool
Wednesday, July 11, 2012 - 12:39pm
tags:
earnings, JNJ
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wednesday, July 11, 2012 - 12:12pm
tags:
Xenon, Virobay, Tolero Pharmaceuticals, Threshold Pharmaceuticals, Novartis, Merck KGaA, Merck, MannKind, licensing, Janssen, Isis Pharmaceuticals, Ironwood, Inhibrx Thrombogenics, GSK, Genmab, Genentech, Galapagos, Forma Therapeutics, Endocyte, Endo, Enanta, Celgene, Bristol-Myers Squibb, Boehringer Ingelheim, Bionomics, Biogen Idec, BioDelivery Sciences, AstraZeneca, Angiochem, AC Immune, Abbott Laboratories, LEO Pharma
Lilly could net $1.5B-plus from Cymbalta extension
Fierce Pharma
Wednesday, July 11, 2012 - 12:08pm
tags:
Eli Lilly, Cymbalta, antidepressants
The Butterfly Effect Of The Affordable Care Act
Seeking Alpha
Wednesday, July 11, 2012 - 12:05pm
tags:
Affordable Care Act, healthcare reform, Abbott Laboratories, Merck, Pfizer, Unitedhealth Group, Wellpoint
Pfizer Is Worth $25 Despite Lawsuits And Lipitor Patent Expiry
Forbes
Wednesday, July 11, 2012 - 12:04pm
tags:
Lipitor, Pfizer, patents
Closer Look: Furiex's Big Bounce
Seeking Alpha
Wednesday, July 11, 2012 - 12:04pm
tags:
Furiex Pharmaceuticals, JNJ, Takeda, Eli Lilly
Eli Lilly treatment for acute schizophrenia fails in late-stage study comparing it to placebo
Yahoo/AP
Wednesday, July 11, 2012 - 11:42am
tags:
Eli Lilly, schizophrenia, antipsychotics, pomaglumetad methionil
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test
Bloomberg
Wednesday, July 11, 2012 - 10:19am
tags:
GSK, HIV, AIDS, Shionogi, Gilead, Atripla, Dolutegravir
Eisai's Halavan misses endpoints in Phase III trial
Pharma Times, UK
Wednesday, July 11, 2012 - 10:06am
tags:
Eisai, Halavan, Xeloda, breast cancer
J&J-Pfizer Drug Long Shot Against Alzheimer’s
Bloomberg Businessweek
Wednesday, July 11, 2012 - 9:48am
tags:
Alzheimer's disease, Pfizer, JNJ, bapineuzumab
Why Hedge Funds Prefer Vivus Over Arena
Seeking Alpha
Wednesday, July 11, 2012 - 9:46am
tags:
Vivus, Arena, Qnexa, Belviq, GSK, Orexigen
Orexigen's Light Study for Contrave enrolling faster than projected
Yahoo/Fly on the Wall
Wednesday, July 11, 2012 - 9:43am
tags:
Orexigen, Contrave
June Meeting Between Amarin and FDA May Have Decided Fate of Fish-Oil Pill
TheStreet.com
Wednesday, July 11, 2012 - 9:29am
tags:
FDA, Amarin, AMR101
Allergan estimates lowered on CVS/Caremark exclusion, says Leerink
The Fly on the Wall
Tuesday, July 10, 2012 - 1:05pm
tags:
Allergan, CVS, Caremark

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.